Board Meeting29 Oct 2026, 03:36 pm
Jenburkt Pharmaceuticals Board Meeting on Nov 3, 2026
AI Summary
Jenburkt Pharmaceuticals Ltd has announced that a meeting of its Board of Directors is scheduled for November 3, 2026. The primary agenda item is to consider and approve the standalone unaudited financial results for the quarter and half-year ended September 30, 2026. This meeting will provide an update on the company's financial performance for the specified periods.
Key Highlights
- Board meeting scheduled for November 3, 2026.
- Agenda includes approval of standalone unaudited financial results.
- Results pertain to the quarter and half-year ended September 30, 2026.
- Company to take on record the financial performance for the period.
Price Impact
More from JENBURPH
Shareholding1h ago
Jenburkt Pharma: Counter Cyclical Investment Buys 4,608 Shares
Quarterly Result1d ago, 6:11 pm
Jenburkt Pharmaceuticals Declares Standalone Unaudited Q2 FY27 Results
Quarterly Result1d ago, 6:00 pm
Jenburkt Q2 FY27: PAT flat YoY at ₹10.2 Cr as margins compress despite 6% revenue growth